Daiichi Sankyo Company Limited
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 rec… Read more
Daiichi Sankyo Company Limited - Asset Resilience Ratio
Daiichi Sankyo Company Limited (DSKYF) has an Asset Resilience Ratio of 1.44% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2025)
This chart shows how Daiichi Sankyo Company Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Daiichi Sankyo Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $51.44 Billion | 1.44% |
| Total Liquid Assets | $51.44 Billion | 1.44% |
Asset Resilience Insights
- Limited Liquidity: Daiichi Sankyo Company Limited maintains only 1.44% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Daiichi Sankyo Company Limited Industry Peers by Asset Resilience Ratio
Compare Daiichi Sankyo Company Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367 |
Drug Manufacturers - General | 32.14% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
Drug Manufacturers - General | 0.00% |
|
PharmGen Science Inc
KO:004720 |
Drug Manufacturers - General | 0.16% |
Annual Asset Resilience Ratio for Daiichi Sankyo Company Limited (2003–2025)
The table below shows the annual Asset Resilience Ratio data for Daiichi Sankyo Company Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 2.34% | $80.89 Billion | $3.46 Trillion | -14.33pp |
| 2024-03-31 | 16.67% | $577.04 Billion | $3.46 Trillion | +5.80pp |
| 2023-03-31 | 10.87% | $272.74 Billion | $2.51 Trillion | +0.59pp |
| 2022-03-31 | 10.28% | $228.44 Billion | $2.22 Trillion | -5.78pp |
| 2021-03-31 | 16.06% | $334.94 Billion | $2.09 Trillion | +4.68pp |
| 2020-03-31 | 11.38% | $239.61 Billion | $2.11 Trillion | -8.04pp |
| 2019-03-31 | 19.42% | $405.51 Billion | $2.09 Trillion | +1.71pp |
| 2018-03-31 | 17.71% | $336.16 Billion | $1.90 Trillion | -11.12pp |
| 2017-03-31 | 28.83% | $552.16 Billion | $1.91 Trillion | +2.92pp |
| 2016-03-31 | 25.92% | $492.57 Billion | $1.90 Trillion | +16.51pp |
| 2015-03-31 | 9.41% | $186.46 Billion | $1.98 Trillion | -8.08pp |
| 2014-03-31 | 17.48% | $324.16 Billion | $1.85 Trillion | +6.66pp |
| 2013-03-31 | 10.82% | $182.37 Billion | $1.68 Trillion | +3.64pp |
| 2012-03-31 | 7.19% | $111.71 Billion | $1.55 Trillion | -3.46pp |
| 2011-03-31 | 10.65% | $157.65 Billion | $1.48 Trillion | -5.23pp |
| 2010-03-31 | 15.88% | $236.54 Billion | $1.49 Trillion | +0.13pp |
| 2009-03-31 | 15.76% | $235.47 Billion | $1.49 Trillion | -19.65pp |
| 2008-03-31 | 35.41% | $526.80 Billion | $1.49 Trillion | +7.98pp |
| 2007-03-31 | 27.42% | $448.90 Billion | $1.64 Trillion | +10.23pp |
| 2006-03-31 | 17.20% | $274.51 Billion | $1.60 Trillion | +2.18pp |
| 2005-03-31 | 15.02% | $146.63 Billion | $976.23 Billion | +4.92pp |
| 2004-03-31 | 10.10% | $93.61 Billion | $927.24 Billion | -2.17pp |
| 2003-03-31 | 12.27% | $112.33 Billion | $915.79 Billion | -- |